Astatine-211 is a radioactive isotope of the element astatine, which has the atomic number 85. It is notable for its relatively short half-life of about 7.2 hours and emits alpha particles during its decay process. The main use of astatine-211 is in targeted alpha-particle therapy for cancer treatment. Its alpha emissions can destroy cancer cells with minimal damage to surrounding healthy tissue, making it suitable for use in radiopharmaceuticals that selectively target tumors. Researchers are investigating astatine-211 for its potential in treating various cancers, including leukemia, lymphoma, and certain solid tumors.

Please complete the form below to receive immediate access to Nusano’s radioisotope product fact sheet. The document provides the following product specifications:

• Radiochemical Purity
• Radioactivity Concentration
• Specific Activity
• Elemental Impurities
• Bacterial Endotoxins (BET)
• Sterility
• Production Route
• Unit of Sale